Back to User profile » Dr Federica Zoratto
Papers published by Dr Federica Zoratto:
Angiogenesis and antiangiogenic agents in cervical cancer
Tomao F, Papa A, Rossi L, Zaccarelli E, Caruso D, Zoratto F, Benedetti Panici P, Tomao S
OncoTargets and Therapy 2014, 7:2237-2248
Published Date: 3 December 2014
Metastatic colorectal cancer first-line treatment with bevacizumab: the impact of K-ras mutation
Rossi L, Veltri E, Zullo A, Zoratto F, Colonna M, Longo F, Mottolese M, Giannarelli D, Ruco L, Marchetti P, Romiti A, Barucca V, Giannini G, Bianchi L, Tomao S
OncoTargets and Therapy 2013, 6:1761-1769
Published Date: 29 November 2013
Factors influencing choice of chemotherapy in metastatic colorectal cancer (mCRC)
Rossi L, Vakiarou F, Zoratto F, Bianchi L, Papa A, Basso E, Verrico M, Lo Russo G, Evangelista S, Rinaldi G, Perrone-Congedi F, Spinelli GP, Stati V, Caruso D, Prete A, Tomao S
Cancer Management and Research 2013, 5:377-385
Published Date: 19 November 2013
Efficacy and safety analysis of once per cycle pegfilgrastim and daily lenograstim in patients with breast cancer receiving adjuvant myelosuppressive chemotherapy FEC 100: a pilot study
Rossi L, Tomao F, Lo Russo G, Papa A, Zoratto F, Marzano R, Basso E, Giordani E, Verrico M, Ricci F, Pasciuti G, Francini E, Tomao S
Therapeutics and Clinical Risk Management 2013, 9:457-462
Published Date: 11 November 2013
Critical appraisal of bevacizumab in the treatment of metastatic colorectal cancer
Zoratto F, Rossi L, Zullo A, Papa A, Zaccarelli E, Tomao L, Giordani E, Colonna M, Baiano G, Tomao S
OncoTargets and Therapy 2012, 5:199-211
Published Date: 24 September 2012